At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported on Wednesday in The BMJ
Conflict of interest The authors declare no conflict of interest Authors contributions Conceptualization, formal analysis, original draft preparation (SKC), writingreview and editing (SKC, DC), supervision, project administration, and funding acquisition (SKC)
The two therapies work in tandem: one purifies at the cellular level, the other clears the pathways that carry waste away
[PubMed: 10716495] 272
Directions for use: Use 2 capsules once/twice a day: after a main meal or before training Wash down with a lot of water (at least 250-300 ml)
La participani cu obezitate sau suprapondere fr diabet, administrarea sptmnal de Tirzepatide (5/10/15 mg) timp de 72 de sptmni duce la o reducere semnificativ i susinut a greutii corporale, iar rezultatele sunt interpretate ca efect al influenei combinate asupra reglrii apetitului i cilor metabolice
